Cardinal Health, Inc. (NYSE:CAH) has been given an average rating of “Hold” by the twenty-two research firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, sixteen have given a hold rating and five have issued a buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $83.35.

CAH has been the topic of several research analyst reports. Zacks Investment Research lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a research report on Friday, April 28th. Credit Suisse Group restated a “buy” rating and issued a $81.00 price target on shares of Cardinal Health in a research note on Tuesday, May 2nd. William Blair downgraded shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 19th. Tigress Financial started coverage on shares of Cardinal Health in a research note on Friday, April 28th. They issued a “neutral” rating on the stock. Finally, Jefferies Group LLC started coverage on shares of Cardinal Health in a research note on Wednesday, May 17th. They issued a “hold” rating and a $77.00 price target on the stock.

In other news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $72.87, for a total value of $1,695,684.90. Following the completion of the transaction, the insider now owns 55,440 shares of the company’s stock, valued at $4,039,912.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.94% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Advisory Services Network LLC acquired a new position in shares of Cardinal Health during the first quarter worth about $120,000. Quadrant Capital Group LLC raised its position in shares of Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock worth $156,000 after buying an additional 116 shares during the period. Alpha Windward LLC raised its position in Cardinal Health by 1.8% in the first quarter. Alpha Windward LLC now owns 2,282 shares of the company’s stock valued at $186,000 after buying an additional 41 shares during the last quarter. MCF Advisors LLC raised its position in Cardinal Health by 11.5% in the first quarter. MCF Advisors LLC now owns 2,478 shares of the company’s stock valued at $202,000 after buying an additional 256 shares during the last quarter. Finally, First Mercantile Trust Co. raised its position in Cardinal Health by 18.5% in the first quarter. First Mercantile Trust Co. now owns 2,539 shares of the company’s stock valued at $207,000 after buying an additional 397 shares during the last quarter. Institutional investors and hedge funds own 87.52% of the company’s stock.

Cardinal Health (CAH) traded down 1.33% during mid-day trading on Friday, reaching $76.29. 2,052,733 shares of the company’s stock traded hands. Cardinal Health has a 1-year low of $62.70 and a 1-year high of $85.52. The firm has a 50 day moving average of $76.85 and a 200 day moving average of $77.11. The firm has a market cap of $24.10 billion, a PE ratio of 18.21 and a beta of 0.81.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Monday, May 1st. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.46 by $0.07. The company had revenue of $31.82 billion for the quarter, compared to analyst estimates of $32.30 billion. Cardinal Health had a net margin of 1.05% and a return on equity of 25.78%. The company’s revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.43 earnings per share. Analysts forecast that Cardinal Health will post $5.35 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Saturday, July 15th. Stockholders of record on Monday, July 3rd were issued a $0.4624 dividend. The ex-dividend date was Thursday, June 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.42%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.45. Cardinal Health’s dividend payout ratio is 44.05%.

ILLEGAL ACTIVITY WARNING: “Cardinal Health, Inc. (NYSE:CAH) Given Average Rating of “Hold” by Brokerages” was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/07/21/cardinal-health-inc-nysecah-given-average-rating-of-hold-by-brokerages.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.